10x Genomics Shares Drop 10.9% Amid Market Volatility

Analysts remain divided on the stock's outlook as the biotech company faces headwinds.

Mar. 16, 2026 at 6:35pm

Got story updates? Submit your updates here. ›

Shares of 10x Genomics (NASDAQ:TXG) fell 10.9% on Monday, trading as low as $16.29 amid broader market volatility. The company, which specializes in advanced genomic analysis solutions, saw its stock price decline despite reporting better-than-expected earnings in its latest quarter. Analysts have a mixed outlook on the stock, with some maintaining a 'hold' rating while others see potential upside.

Why it matters

10x Genomics is a key player in the rapidly evolving field of genomics, providing tools and technologies that enable researchers to explore biology at unprecedented resolution. The company's performance is closely watched as an indicator of broader trends in the life sciences and biotechnology sectors, which have faced volatility in recent months due to macroeconomic factors.

The details

The drop in 10x Genomics' share price on Monday came despite the company reporting Q4 2025 earnings that exceeded analyst expectations. The stock's decline was likely driven by broader market turbulence, as investors remain cautious amid concerns about economic growth and interest rate hikes. Analysts have a mixed outlook on the stock, with some maintaining a 'hold' rating due to valuation concerns, while others see potential upside based on the company's innovative product portfolio and long-term growth prospects.

  • 10x Genomics shares fell 10.9% on Monday, March 16, 2026.

The players

10x Genomics

A biotechnology company that specializes in advanced genomic analysis solutions, enabling researchers to explore biology at unprecedented resolution.

Got photos? Submit your photos here. ›

The takeaway

The volatility in 10x Genomics' stock price underscores the challenges facing the broader biotech and life sciences sectors, as investors navigate macroeconomic headwinds and assess the long-term growth potential of innovative companies in this rapidly evolving field.